Clinical Trial Update: HAIC Plus Lenvatinib and Toripalimab for Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing hepatic arterial infusion chemotherapy (HAIC) plus lenvatinib and toripalimab for advanced hepatocellular carcinoma has been co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HAIC (hepatic artery infusion chemotherapy)
• Lenvatinib (lenvatinib)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shi Ming | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED